AR004388A1 - Anticuerpos que reconocen cadenas de azucares y remedios para enfermedades infecciosas por vih - Google Patents

Anticuerpos que reconocen cadenas de azucares y remedios para enfermedades infecciosas por vih

Info

Publication number
AR004388A1
AR004388A1 ARP960105720A ARP960105720A AR004388A1 AR 004388 A1 AR004388 A1 AR 004388A1 AR P960105720 A ARP960105720 A AR P960105720A AR P960105720 A ARP960105720 A AR P960105720A AR 004388 A1 AR004388 A1 AR 004388A1
Authority
AR
Argentina
Prior art keywords
sugar chains
beta
remedies
infectious diseases
antibodies recognizing
Prior art date
Application number
ARP960105720A
Other languages
English (en)
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of AR004388A1 publication Critical patent/AR004388A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención está dirigida a un anticuerpo que reconoce cadenas de azúcares, el cual pertenece al isotipo IgM y que reconoce Gg4Cer (Gal Beta 1-3 GalNAc Beta 1 - 4Gal Beta 1 - 4Glc Beta Cer) o GM2 que aparece en las células infectadas con VIH, así como a un producto terapéutico para lasenfermedades por VIH conteniendo esas IgMs.
ARP960105720A 1995-12-18 1996-12-17 Anticuerpos que reconocen cadenas de azucares y remedios para enfermedades infecciosas por vih AR004388A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP32901095 1995-12-18

Publications (1)

Publication Number Publication Date
AR004388A1 true AR004388A1 (es) 1998-11-04

Family

ID=18216600

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960105720A AR004388A1 (es) 1995-12-18 1996-12-17 Anticuerpos que reconocen cadenas de azucares y remedios para enfermedades infecciosas por vih

Country Status (11)

Country Link
US (1) US6190863B1 (es)
EP (1) EP0870509B1 (es)
KR (1) KR100468899B1 (es)
CN (1) CN1171638C (es)
AR (1) AR004388A1 (es)
AT (1) ATE298247T1 (es)
AU (1) AU719412B2 (es)
DE (1) DE69634879T2 (es)
MX (1) MX9804880A (es)
TW (1) TW505656B (es)
WO (1) WO1997022361A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1533320B1 (en) * 2002-07-01 2009-02-18 Nagoya Industrial Science Research Institute HUMAN IgM ANTIBODY INDUCING APOPTOSIS IN HIV-INFECTED CELLS AND REMEDY FOR HIV-INFECTION
AU2003244159A1 (en) * 2002-07-01 2004-01-19 Hidechika Okada HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT
US9139607B2 (en) * 2002-12-26 2015-09-22 Sumitomo Bakelite Co., Ltd. Method of purifying/concentrating sugar chain with sugar chain-trapping molecule and method of analyzing sugar chain structure
JP6811723B2 (ja) 2015-04-17 2021-01-13 アイジーエム バイオサイエンシズ インコーポレイテッド 多価ヒト免疫不全ウイルス抗原結合分子およびその使用方法

Also Published As

Publication number Publication date
EP0870509A4 (en) 2001-04-18
TW505656B (en) 2002-10-11
KR100468899B1 (ko) 2006-08-18
EP0870509A1 (en) 1998-10-14
AU719412B2 (en) 2000-05-11
AU1111397A (en) 1997-07-14
DE69634879D1 (de) 2005-07-28
EP0870509B1 (en) 2005-06-22
DE69634879T2 (de) 2005-11-24
CN1171638C (zh) 2004-10-20
ATE298247T1 (de) 2005-07-15
CN1205642A (zh) 1999-01-20
US6190863B1 (en) 2001-02-20
KR20000064360A (ko) 2000-11-06
WO1997022361A1 (fr) 1997-06-26
MX9804880A (es) 1998-10-31

Similar Documents

Publication Publication Date Title
NO951212L (no) Humane nöytraliserende monoklonale antistoffer mot humant immunsviktvirus
DE69233435D1 (de) Vorläufer von für tumorabstossung verantwortlichen antigenen, die antigene und deren verwendungen
DE69435126D1 (de) Synthetische humane neutralisierende monoklonale antikörper gegen hiv
AU2308595A (en) Monoclonal antibodies against hiv-1 and vaccines made thereo f
ES2099158T3 (es) Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo.
FI942359A (fi) Lajiin Staphylococcus epidermidis liityviä tyyppi I ja tyyppi II -pinta-antigeenejä
NO913428D0 (no) Humant intra-acrosomalt sperma-antigen for anvendelse i en befruktningshindrende vaksine.
SE8703225L (sv) Monoklonala antikroppar och peptider anvendbara vid behandling och diagnostisering av hiv-infektioner
PT98565A (pt) Um processo de producao de uma composicao para o tratamento da infeccao por hsv
AU554080B2 (en) Production of viral antisens
ES2139402T3 (es) Un proceso para preparar una fraccion del acido hialuronico con un bajo indice de polidispersion.
DE3062253D1 (en) Stable aqueous or hydro-alcoholic solutions of fat-soluble perfume oils
BR9814432A (pt) Composições derivadas de mycobacterium vaccae e processo para seu uso
AR004388A1 (es) Anticuerpos que reconocen cadenas de azucares y remedios para enfermedades infecciosas por vih
ES2053472T3 (es) Procedimiento y reactivo para la determinacion de alfa-amilasa.
ES2059577T3 (es) Fragmentos genicos que codifican para las regiones variables de un anticuerpo anti-hiv, anticuerpos anti-hiv quimericos expresados utilizando los mismos y procedimiento para su preparacion.
AU2456888A (en) Monoclonal antibodies specific for HIV and hybridomas for their production
BG99074A (en) Recombinant human hiv neutralizing monoclonal antibodies for prophylaxy and treatment of hiv infection
GB1486186A (en) Vaccines against feline leukaemia and the group of diseases associated with feline leukaemis/virus infection
PT690725E (pt) Metodos para inibicao de doenca associada a vih que utilizam anticorpos monoclonais dirigidos contra celulas t citotoxicas anti-proprio
DE69213325D1 (de) Gegen das menschliche Immunschwäche-Virus gerichtetes Immunpräparat
EP0327648A4 (en) HUMAN MONOCLONAL ANTIBODIES AND MEDICINES FOR PROPHYLAXIS AND TREATMENT OF INFECTIOUS DISEASES.
WO1988007080A3 (en) Transgenic animal cells resistant to viral infection
CA2239596A1 (en) Sugar-chain-recognizing antibodies and remedies for hiv infectious diseases
Banoun African Journal of Biological Sciences